Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00145041
What this trial is testing

Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction

Who this might be right for
Malignant Melanoma
Acrotech Biopharma Inc. 7
Early research (Phase 1)Active Not RecruitingNCT01366144
What this trial is testing

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryEndometrial Carcinoma+11 more
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Study completedNCT03278665
What this trial is testing

4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy

Who this might be right for
Malignant Melanoma
4SC AG 40
Testing effectiveness (Phase 2)Study completedNCT04382664
What this trial is testing

UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma

Who this might be right for
Malignant Melanoma
Ultimovacs ASA 156
Testing effectiveness (Phase 2)Study completedNCT00949702
What this trial is testing

Vemurafenib in Previously Treated Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 132
Testing effectiveness (Phase 2)Ended earlyNCT00722098
What this trial is testing

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

Who this might be right for
Malignant Melanoma Stage IV
Baylor Research Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT00733798
What this trial is testing

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Who this might be right for
MelanomaMalignant MelanomaMetastatic Melanoma
TransMolecular 58
Large-scale testing (Phase 3)Study completedNCT00518895
What this trial is testing

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Who this might be right for
Melanoma
Genta Incorporated 300
Testing effectiveness (Phase 2)Study completedNCT00086489
What this trial is testing

CP-675,206 In Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
AstraZeneca 118
Testing effectiveness (Phase 2)Study completedNCT01253096
What this trial is testing

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 25
Early research (Phase 1)UnknownNCT00022568
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03780608
What this trial is testing

This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)

Who this might be right for
Gastric AdenocarcinomaMalignant Melanoma
Samsung Medical Center 61
Testing effectiveness (Phase 2)Ended earlyNCT01495572
What this trial is testing

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT01001299
What this trial is testing

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 25
Testing effectiveness (Phase 2)Study completedNCT01654692
What this trial is testing

A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Italian Network for Tumor Biotherapy 86
Not applicableUnknownNCT04158544
What this trial is testing

Immune Monitoring in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Regensburg 100
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Testing effectiveness (Phase 2)Study completedNCT02523313
What this trial is testing

Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 167
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Next Page